Nastolatek ucząca się w domu, skupiona na notatkach

Citicoline (CDP-Choline) and Concentration: What Does the Research Actually Show?

Citicoline is often marketed as an all-purpose nootropic for memory, mood, and focus at once. The evidence, however, is uneven — the most solidly documented effect isn't memory, but a narrower, more specific domain: psychomotor speed and attention. We check what studies on healthy teenagers and adults actually found, how much of that effect can be attributed to citicoline itself versus the caffeine present alongside it in some studies, and why it's worth knowing who funded a study before treating its result as final.

Redakcja VitMode — Sen i neurobiologiathe VitMode editorial team, no individual bylinesPublishedSeptember 10, 202613 min readAbout 13 min left

How this article was made

Author: Redakcja VitMode — Sen i neurobiologia — the VitMode editorial team, no individual bylines
Method: Prepared from primary sources: clinical trials, meta-analyses and guidelines. We describe study findings separately from our interpretation.
Source verification: Cited PubMed papers are automatically checked for a matching identifier, title and publication year.
Medical review: none — this article has not been reviewed by a physician
Last updated: September 10, 2026

The content is educational and does not replace medical advice. Read the full editorial process

Table of contents

TL;DR — key takeaways

→Citicoline — a nootropic with a narrower, more specific profile than it seems
→The mechanism specifically relevant to attention: acetylcholine and conduction speed
→A study of 75 healthy teenagers: improved attention and psychomotor speed
→Citicoline with caffeine: a stronger effect, but harder to attribute to a single ingredient
→What about memory? A different domain, with different (and not stronger) evidence
→Who funds these studies — and why it's worth asking
→Who a concentration effect might genuinely matter for
→Safety and practical dosing
→Citicoline compared with other "concentration" nootropics
→Our editorial recommendation

Citicoline — a nootropic with a narrower, more specific profile than it seems

Citicoline (CDP-choline, cytidine-5'-diphosphocholine) is a compound that occurs naturally in the body as an intermediate in the production of phosphatidylcholine — the main phospholipid of neuronal cell membranes. We've covered the compound's full profile, its history of medical use after stroke, and its mechanism in detail in our knowledge-base entry on citicoline — here we focus exclusively on one specific question: what the evidence says about citicoline's effect on concentration, attention, and reaction speed in healthy people, not its full supplementation profile.

This distinction matters, because marketing for citicoline supplements often blends together different, not equally well-documented domains — memory in older adults, concentration in healthy young people, mood, and even recovery after brain injury — as if it were one uniform effect. In reality, the evidence varies in strength and quality depending on which of these domains it concerns. The most consistent and reproducible signal concerns precisely attention and psychomotor speed — and that's what this article is about.

The mechanism specifically relevant to attention: acetylcholine and conduction speed

Once absorbed, citicoline is broken down into choline and cytidine, which are resynthesized inside neurons after crossing the blood-brain barrier. The choline released in this process is a direct precursor of acetylcholine — a neurotransmitter that plays a key role not only in long-term memory, but above all in attention systems: cortical arousal networks, the speed of stimulus processing, and the ability to sustain focus on a task over time (so-called sustained attention).

This distinguishes the theoretical basis for an effect on concentration from an effect on long-term memory, which is tied more to the structural integrity of hippocampal neuron membranes (built from phosphatidylcholine) than to the moment-to-moment availability of acetylcholine at the synapse. In other words — it's mechanistically plausible that citicoline could affect attention faster and more noticeably than memory, since the acetylcholine pathway operates on a scale of minutes to hours, while remodeling neuronal membranes is a process of weeks.

A study of 75 healthy teenagers: improved attention and psychomotor speed

What does the research say?

The Effect of Citicoline Supplementation on Motor Speed and Attention in Adolescent Males

McGlade E, Agoston AM, DiMuzio J, Kizaki M, Nakazaki E, Kamiya T, Yurgelun-Todd D · Journal of Attention Disorders, 23(2), 121–134 · 2019

Study findings

A randomized, placebo-controlled trial in 75 healthy males aged 15-21, assigned to a citicoline group (250 or 500 mg daily, n=51) or placebo (n=24) for 28 days. Attention and impulsivity were measured with the Ruff 2&7 Selective Attention Test and the Computerized Performance Test (CPT-II), and psychomotor speed with the Finger Tap Test. The citicoline group showed a significant improvement in attention (p=0.02) and psychomotor speed (p=0.03) relative to placebo. A higher dose (per kilogram of body weight) was additionally associated with better accuracy on the attention task (p=0.01), better signal detection on the computerized task (p=0.03), and lower impulsivity (p=0.01).

Moderate evidenceView the study on PubMed

This describes what the study found. Editorial interpretation follows in the text below.

This is one of the most frequently cited studies in discussions of citicoline and concentration, because — unlike many earlier citicoline studies — it involved a healthy, young population rather than stroke or dementia patients. The dose-response relationship (a stronger effect at a higher dose per kilogram of body weight) is an additional argument that the observed effect is a genuine biological signal rather than a statistical fluke.

Citicoline with caffeine: a stronger effect, but harder to attribute to a single ingredient

What does the research say?

Improvements in concentration, working memory and sustained attention following consumption of a natural citicoline-caffeine beverage

Bruce SE, Werner KB, Preston BF, Baker LM · International Journal of Food Sciences and Nutrition, 65(8), 1003–1007 · 2014

Study findings

A randomized, double-blind, placebo-controlled trial in 60 healthy adults, evaluating a beverage containing citicoline and caffeine. The study group showed significantly faster maze-learning time and faster reaction time on a continuous performance test, fewer errors on a go/no-go task, and better accuracy on an information-processing-speed measure relative to placebo. EEG recordings showed a higher-amplitude P450 evoked potential, which the authors interpreted as an increase in sustained attention.

Early-stage evidenceView the study on PubMed

This describes what the study found. Editorial interpretation follows in the text below.

What about memory? A different domain, with different (and not stronger) evidence

In our knowledge-base entry on citicoline, we describe a separate study — Nakazaki et al. (2021, The Journal of Nutrition) — in which 500 mg of citicoline daily for 12 weeks improved overall memory performance, particularly episodic memory, in older adults with age-related memory decline. That's an important study, but it answers a different question than concentration in a younger, healthy population — a different target mechanism (membrane remodeling in the hippocampus), a different age group, and a different endpoint.

Myth

Since citicoline "improves cognitive function" in studies, you can expect better memory, concentration, and mood at once in anyone who takes it.

Fact

Evidence for these three domains comes from different studies, in different populations (healthy teenagers vs. older adults with memory decline), different doses, and different intervention durations. An effect on attention in healthy, young people is not the same evidence as an effect on episodic memory in seniors — treating them as one generalized "cognitive support" blurs the real differences in the strength and certainty of the evidence for each domain individually.

Check your profile

Not sure which supplements actually make sense for you?

Answer a few short questions about your lifestyle, diet, sleep, and goals. VitMode will build your profile and show supplements worth considering — with reasoning and evidence strength.

Takes about 2 minutesBased on scientific evidence

Find supplements for me

Recommendations take your answers and the strength of the scientific evidence into account. A supplement's popularity has no bearing on whether it gets recommended.

Who funds these studies — and why it's worth asking

The large majority of newer clinical studies on citicoline in the context of concentration and attention in healthy people — including both studies discussed above — use a patented, standardized form of sodium citicoline sold under the trade name Cognizin®. Studies on patented ingredients are sometimes funded or co-run by the manufacturer or affiliated parties, which doesn't in itself invalidate the results — the methodology (randomization, blinding, control group) in both studies described here is solid — but it's a circumstance worth knowing when interpreting how many independent, industry-unaffiliated replications of a given result actually exist.

Who a concentration effect might genuinely matter for

Worth emphasizing: none of the studies described evaluated citicoline in people with clinically diagnosed ADHD or other attention disorders — both study populations (teenagers in the McGlade study and adults in the Bruce study) were healthy. Extrapolating these results to clinical populations isn't warranted without separate studies in that specific group.

Safety and practical dosing

Citicoline has a well-documented safety profile thanks to decades of clinical use, mainly in the context of neurological rehabilitation after stroke, where doses were considerably higher than in supplementation. Studies on concentration in healthy people used doses of 250-500 mg daily — consistent with the typical range found in supplements on the market.

Citicoline compared with other "concentration" nootropics

Question	Short answer
Is there evidence for improved attention?	Yes — an RCT in 75 healthy teenagers showed a significant improvement in attention and psychomotor speed
Is the effect strong or subtle?	Subtle — comparable to mild support, not to classic stimulants
Are the studies independent of the manufacturer?	Mostly not — most newer studies involve the patented Cognizin® form and are linked to its manufacturer
Is evidence for concentration the same as evidence for memory?	No — these are separate studies, in different populations (healthy young people vs. older adults with memory decline)
What dose was studied?	250-500 mg daily in concentration studies, over periods from 28 days to 12 weeks

Citicoline and concentration — at a glance

Our editorial recommendation

Among the many nootropics sold with a promise of improved concentration, citicoline is one of those with relatively more solid, though still moderate, research support — a randomized trial in healthy teenagers showed a consistent, statistically significant, dose-dependent effect on attention. That's more than can be said for many popular nootropics sold on the strength of a purely theoretical mechanism.

At the same time, it's worth keeping proportions in mind: this is a subtle effect, studied mainly in research linked to the manufacturer of a patented form, in a narrow, healthy population. People expecting a dramatic improvement in focus will likely be disappointed — people looking for mild, well-tolerated attention support have a more solid basis than with many competing supplements.

Citicoline isn't a miracle concentration aid — it's one of the few nootropics where a modest but real effect on attention actually has a randomized trial in healthy people behind it, not just biochemical theory.

VitMode editorial team

Frequently asked questions

A study of 75 healthy teenagers (McGlade et al., 2019) showed a statistically significant improvement in attention (p=0.02) and psychomotor speed (p=0.03) after 28 days of supplementation with 250-500 mg daily. That's more solid evidence than for many other nootropics, though the effect is subtle, not dramatic.

It depends on the study. The McGlade et al. study tested citicoline alone, without caffeine, and found an effect. Another study (Bruce et al., 2014) tested a beverage combining citicoline with caffeine — in that case, it's impossible to clearly separate each ingredient's contribution. It's worth checking a specific product's composition.

Studies on concentration in healthy people used 250-500 mg daily. Higher doses (1000-2000 mg) are used in a clinical context under medical supervision and don't apply to standard concentration-focused supplementation.

Not fully — most newer studies involve the patented Cognizin® form and are funded by or linked to its manufacturer. The studies' methodology (randomization, blinding) is solid, but it's worth knowing about this connection when assessing how many independent replications exist.

No — these are separate domains studied in separate trials, in different populations. Evidence for improved memory concerns mainly older adults with age-related memory decline (Nakazaki et al., 2021, described in our knowledge base), while evidence for concentration concerns mainly healthy, young people.

It has a well-documented safety profile thanks to decades of clinical use. Possible mild side effects include headaches at higher doses and rare gastrointestinal complaints. People on cholinergic medications and pregnant or breastfeeding women should consult a doctor before supplementing.

There's no direct evidence for this — the studies described involved healthy people without diagnosed attention disorders. Extrapolating results to clinical populations, including ADHD, isn't warranted without separate studies in that specific group.

A study of a beverage combining both ingredients showed a strong effect on attention and reaction speed, but it doesn't allow assessing how much of that comes from citicoline alone. If the goal is to evaluate citicoline's own effect, it's better to test it separately, without additional caffeine stimulation.

Sources (2)

Sources are numbered. PubMed items are automatically verified (identifier, title, year).

Redakcja VitMode — Sen i neurobiologia

VitMode editorial team — no individual bylines; content based on primary sources

VitMode Editorial — Sleep and Neurobiology is the VitMode editorial team responsible for: sleep, circadian rhythm, cognition and recovery. The team has no individual bylines — texts are prepared by VitMode editors from primary sources (clinical trials, meta-analyses, guidelines). Every cited PubMed paper is automatically checked for a matching identifier, title and publication year. The content is educational and does not replace medical advice. Factual errors can be reported in a comment under the post or through the contact form; corrections are made by the editorial team.